Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Pedersen, R. Pauwels, W. Busse, W. Tan, Y. Z. Chen, C. J. Lamm, P. O‘Byrne (Kolding, Denmark; Ghent, Belgium; Madison, United States Of America; Singapore, Singapore; Beijing, China; Lund, Sweden; Hamilton, Canada). Effect of 5 years of budesonide treatment on growth and adult height in asthmatic children: results from the START study. Eur Respir J 2004; 24: Suppl. 48, 1343

Member's Comments

No comment yet.

Related content which might interest you: Economic evaluation of eformoterol compared with salmeterol in children aged 6-17 years with symptomatic asthma in the UK: cost-effectiveness results of the FACT study Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001 Reduction in percent of days with asthma symptoms and activity limitation in young asthmatic children treated with Montelukast Source: Eur Respir J 2001; 18: Suppl. 33, 290s Year: 2001 Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Comparing asthma phenotypes in adults and children: a cohort of two years Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies Year: 2007 Follow-up results 10 years after early intervention with budesonide or terbutaline in mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 667s Year: 2006 Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Efficacy of montelukast in patients aged 2 to 5 years with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 377s Year: 2004 Montelukast and steroid effects on airway function compared with steroid alone and placebo: a single blind, controlled study in asthmatic school children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Montelukast vs. fluticasone in patients aged 6 to 14 with mild persistent asthma: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 377s Year: 2004 The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children Source: Eur Respir J 2006; 27: 316-320 Year: 2006 Comparative study of 8-weeks treatment of asthma exacerbations in adults with high doses of budesonide versus fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001 Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Adult height in children treated with inhaled budesonide is normal but reached late Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006 A comparison of nebulized budesonide, intramuscular and oral dexamethasone in the treatment of croup among children aged 6-36 months Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003 Early exposure to bio-contaminants and asthma up to 10 years of age: results of the HITEA study Source: Eur Respir J 2015; 45: 328-337 Year: 2015 Low dose inhaled fluticasone propionate compared with montelukast in children 6-12 years old Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003 Fracture rate in patients with asthma receiving long-term early intervention with budesonide: the START study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Prevalence rates of asthma, rhinitis and eczema in a large sample of Italian schoolchildren (age 6-7 yrs): preliminary results of SIDRIA2, the Italian ISAAC-phase III Source: Eur Respir J 2003; 22: Suppl. 45, 505s Year: 2003 Effect of montelukast (ML) of an additional therapy in steroid dependent children with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003